Behavior in the open field predicts the number of KCl-induced cortical spreading depressions in rats

Behavioural Brain Research

Volumn 236, Issue 1, 2013, Pages 90-93

  Bogdanov, Volodymyr Borysovych ^a,c   Bogdanova, Olena Viktorivna ^b,c   Koulchitsky, Stanislav Vladimirovich ^a   Chauvel, Virginie ^a   Multon, Sylvie ^a   Makarchuk, Mykola Yukhymovych ^b   Brennan, Kevin Christopher ^c   Renshaw, Perry Franklin ^c   Schoenen, Jean ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Anxiety; Cortical spreading depression; Riboflavin; Valproate

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXPLORATORY BEHAVIOR; MALE; MIGRAINE WITH AURA; NONHUMAN; OCCIPITAL CORTEX; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

ANIMALS; ANTIMANIC AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CORTICAL SPREADING DEPRESSION; ELECTRODES, IMPLANTED; ELECTROPHYSIOLOGY; MALE; MIGRAINE DISORDERS; MOTOR ACTIVITY; OCCIPITAL LOBE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RIBOFLAVIN; VALPROIC ACID; VITAMINS;

EID: 84865989427     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.08.004     Document Type: Article

References (25)

1. Baskin S.M., Smitherman T.A. Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurological Sciences 2009, 30(Suppl. 1):S61-S65.
2. Casucci G., Villani V., Finocchi C. Therapeutic strategies in migraine patients with mood and anxiety disorders: physiopathological basis. Neurological Sciences 2010, 31:S99-S101.
3. Merikangas K.R., Angst J., Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Archives of General Psychiatry 1990, 47:849-853.
4. Wassermann E.M., Greenberg B.D., Nguyen M.B., Murphy D.L. Motor cortex excitability correlates with an anxiety-related personality trait. Biological Psychiatry 2001, 50:377-382.
5. Bogdanov V.B., Multon S., Chauvel V., Bogdanova O.V., Prodanov D., Makarchuk M.Y., et al. Migraine preventive drugs differentially affect cortical spreading depression in rat. Neurobiology of Disease 2010, 41:430-435.
6. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 2003, 463:3-33.
7. Bouwknecht J.A., Spiga F., Staub D.R., Hale M.W., Shekhar A., Lowry C.A. Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Research Bulletin 2007, 72:32-43. [Epub 2007 Jan 16].
8. Thiel C.M., Muller C.P., Huston J.P., Schwarting R.K. High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience 1999, 93:243-251.
9. Kalueff A.V., Fox M.A., Gallagher P.S., Murphy D.L. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes, Brain and Behavior 2007, 6:389-400. [Epub 2006 Aug 29].
10. Barros H.M., Tannhauser S.L., Tannhauser M.A., Tannhauser M. Effect of sodium valproate on the open-field behavior of rats. Brazilian Journal of Medical and Biological Research 1992, 25:281-287.
11. Vinogradova L.V., Kuznetsova G.D., Coenen A.M. Unilateral cortical spreading depression induced by sound in rats. Brain Research 2009, 1286:201-207. [Epub 2009 Jun 25].
12. Akcali D., Sayin A., Sara Y., Bolay H. Does single cortical spreading depression elicit pain behaviour in freely moving rats?. Cephalalgia 2010, 30:1195-1206. [Epub 2010 Mar 31].
13. Bures J., Bohdanecky Z., Weiss T. Physostigmine induced hippocampal theta activity and learning in rats. Psychopharmacologia 1962, 3:254-263.
14. Monmaur P., Sharif A., M'Harzi M. Involvement of septal muscarinic receptors in cholinergically mediated changes in rat rearing activity. Pharmacology Biochemistry and Behavior 1997, 58:577-582.
15. Redolat R., Perez-Martinez A., Carrasco M.C., Mesa P. Individual differences in novelty-seeking and behavioral responses to nicotine: a review of animal studies. Current Drug Abuse Reviews 2009, 2:230-242.
16. Rodrigues P.S., Martins-Ferreira H. Cholinergic neurotransmission in retinal spreading depression. Experimental Brain Research 1980, 38:229-236.
17. Brown C.E., Sweetnam D., Beange M., Nahirney P.C., Nashmi R. Alpha4* nicotinic acetylcholine receptors modulate experience-based cortical depression in the adult mouse somatosensory cortex. Journal of Neuroscience 2012, 32:1207-1219.
18. Schoenen J., Jacquy J., Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998, 50:466-470.
19. Cao B.J., Peng N.A. Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents. European Journal of Pharmacology 1993, 237:177-181.
20. Herzog C.J., Miot S., Mansuy I.M., Giros B., Tzavara E.T. Chronic valproate normalizes behavior in mice overexpressing calcineurin. European Journal of Pharmacology 2008, 580:153-160. [Epub 2007 Oct 25].
21. Flaisher-Grinberg S., Einat H. A possible utilization of the mice forced swim test for modeling manic-like increase in vigor and goal-directed behavior. Journal of Pharmacological and Toxicological Methods 2009, 59:141-145. [Epub 2009 Mar 31].
22. Kuruvilla A., Uretsky N.J. Effect of sodium valproate on motor function regulated by the activation of GABA receptors. Psychopharmacology (Berl) 1981, 72:167-172.
23. Ralph-Williams R.J., Paulus M.P., Zhuang X., Hen R., Geyer M.A. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biological Psychiatry 2003, 53:352-359.
24. Oedegaard K.J., Neckelmann D., Mykletun A., Dahl A.A., Zwart J.A., Hagen K., et al. Migraine with and without aura: association with depression and anxiety disorder in a population-based study. The HUNT Study. Cephalalgia 2006, 26:1-6.
25. Peroutka S.J., Price S.C., Wilhoit T.L., Jones K.W. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Molecular Medicine 1998, 4:14-21.